Sign In
Buy KYTX
$7.82
-0.0800 (-1.01%)
At Close: Jun 03, 2026
The Schall Law Firm Invites Stakeholders Of Kyverna Therapeutics Inc To Join The KYTX Securities Fraud Probe
09:00am, Tuesday, 30'th Jul 2024
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rivian Automotive, Inc. ("Rivian" or "the Company") (NASDAQ:KYTX
The Schall Law Firm Invites Stakeholders Of Kyverna Therapeutics Inc To Join The KYTX Securities Fraud Probe
09:30pm, Monday, 29'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rivian Automotive
The Schall Law Firm Welcomes Stakeholders Of Kyverna Therapeutics Inc To Join The Kytx Securities Fraud Probe
03:15pm, Friday, 26'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rivian Automotive
The Schall Law Firm Welcomes Stakeholders Of Kyverna Therapeutics Inc To Join The KYTX Securities Fraud Probe
03:45pm, Thursday, 25'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rivian Automotive
The Schall Law Firm Welcomes Stakeholders Of Kyverna Therapeutics Inc To Join The KYTX Securities Fraud Probe
08:00pm, Wednesday, 24'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rivian Automotive
The Schall Law Firm Welcomes Stakeholders Of Kyverna Therapeutics Inc To Join The KYTX Securities Fraud Probe
05:45pm, Tuesday, 23'rd Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rivian Automotive
The Schall Law Firm Invites Kyverna Therapeutics Inc Investors To Participate In The Securities Fraud Investigation Into KYTX
03:30pm, Monday, 22'nd Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rivian Automotive
The Schall Law Firm Welcomes Stakeholders Of Kyverna Therapeutics Inc To Join The KYTX Securities Fraud Probe
03:45pm, Friday, 19'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rivian Automotive
Kyverna Therapeutics Inc Investors Are Invited By The Schall Law Firm To Participate In The KYTX Securities Fraud Investigation
03:45pm, Thursday, 18'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rivian Automotive
Investors Of Kyverna Therapeutics Inc Are Welcomed By The Schall Law Firm To Join The KYTX Securities Fraud Probe
02:15pm, Wednesday, 17'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rivian Automotive
Kyverna Therapeutics Inc Investors Are Invited By The Schall Law Firm To Participate In The Securities Fraud Investigation Into KYTX
02:00pm, Tuesday, 16'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rivian Automotive
Kyverna (KYTX) Gets RMAT Designation for CAR T-Cell Product
09:57am, Tuesday, 16'th Jul 2024
The FDA grants the Regenerative Medicine Advanced Therapy ("RMAT") designation to Kyvernas' (KYTX) lead candidate, KYV-101, for the treatment of patients suffering from refractory stiff-person syndrom
The application was evaluated based on the positive clinical outcomes of KYV-101 in patients treated in Germany under a named-patient treatment option The Regenerative Medicine Advanced Therapies desi
The Schall Law Firm Invites Kyverna Therapeutics Inc Investors To Join The Securities Fraud Investigation Into KYTX
02:45pm, Monday, 15'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rivian Automotive
Investors Of Kyverna Therapeutics Inc Are Encouraged By The Schall Law Firm To Participate In The Securities Fraud Probe Into KYTX
05:00pm, Saturday, 13'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rivian Automotive
